Coya Therapeutics Inc. (NASDAQ: COYA) announced that patients in its ALSTARS trial have begun the blinded active-treatment extension phase after ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE